Definium Therapeutics is a late-stage clinical biopharmaceutical company focused on developing accessible treatments for psychiatric and neurological disorders by applying scientific rigor to psychedelics. Our lead product candidate targets anxiety, major depressive disorder, and PTSD, with a pipeline including a treatment for core symptoms of autism spectrum disorder. We aim to address the underlying causes of these disorders and transform mental health care. We are headquartered in New York and trade on Nasdaq under the symbol DFTX.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree